Sampayo Cordero, M., Miguel Huguet, B., Malfettone, A., Pérez García, J. M., Llombart Cussac, A., Cortés, J., . . . Pérez López, J. (2021). The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”.
Citación estilo ChicagoSampayo Cordero, Miguel, Bernat Miguel Huguet, Andrea Malfettone, José Manuel Pérez García, Antonio Llombart Cussac, Javier Cortés, Almudena Pardo, y Jordi Pérez López. The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”. 2021.
Cita MLASampayo Cordero, Miguel, et al. The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”. 2021.